The population of interest in sub-study 1 concerns employees of the SAPV team as well as former relatives of patients in SAPV. In sub-study 2, the entire patient population on the palliative care ward is analysed, regardless of their diagnosis. Among them, 10 participants with gynaecological cancer will be surveyed.
Conditions
Interventions
Group 1: Sub-study 1:
Assessing the current care situation, changes resulting from the introduction of the new technology, worries and concerns of future users and the resulting requirements for the
SUS, Brooke, 1996, German version of Rummel, 2013).
Sponsors
Palliativmedizinische Abteilung der Uniklinik Erlangen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Sub-study 1: - Employees of SPOC teams - (Former) relatives of palliative care patients in SPOC - Very good knowledge of German (fluent communication, even of complex issues) Sub-study 2: Technical feasibility study - Palliative care patients in inpatient care on the palliative care ward of the palliative care department (applicant) - Ability to provide information and consent - Very good knowledge of German (fluent communication, even of complex issues, e.g. treatment goals) - Including n = 10: Women with gynaecological cancers Study on social implications - Palliative care patients in inpatient care on the palliative care ward of the palliative care department - Very good knowledge of German (see above) - For interviews on social implications: Participation in the technical feasibility study for at least 4 days
Exclusion criteria
Exclusion criteria: Sub-study 1 and 2: - No ability to give consent - German language skills are less than very good (see above) Additionally sub-study 2: - Severe paresis (paralysis) of the arms or the dominant arm or the hands or the dominant hand - Severely impaired vision (visual acuity on both sides < 0.5 or on one side < 0.3)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sub-study 1: Data saturation of the semi-structured interviews with medical staff and relatives has been achieved. The effects of implementing the TEAM-X data ecosystem on the roles, characteristics and tasks of the stakeholders and on human-human interactions in specialised palliative outpatient care (SPOC) can be assessed. Sub-study 2: Technical feasibility study: It can be demonstrated that the technology can capture, transmit and store data securely and without loss. Study on social implications: It can be assessed how well the application can be used by the palliative care patient collective, which factors can hinder and promote this and what social implications the introduction could have. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sub-study 1: The planned number of participants has been achieved; n = 11 Requirements for the technical design as well as limits and limitations of the system from the perspective of SAPV staff and relatives of palliative care patients can be presented. Sub-study 2: Technical feasibility study: The planned number of participants has been achieved; n = 60 Aspects of the scope and content of symptom monitoring can be presented. This includes the collection and frequency of data collection and comparability with symptom monitoring data in routine clinical practice. With regard to the collection of data to assess the general condition, the scope should be analysed, i.e. whether mobility data, data on activities of daily living (ADL) and fluid intake can be collected automatically. Study on social implications: The planned number of participants has been achieved; n = 20 (included in the participants of the technical feasibility study) Usage aspects of the TEAM-X system can be characterised and aspects of human-technology interaction can be presented. For the sake of completeness, all sub-studies were listed. For the tab ‘Recruitment period and number of participants’, only the participants of the technical feasibility study are stated. | — |
Countries
Germany
Contacts
Public ContactAlina Weisser
Palliativmedizinische Abteilung der Uniklinik Erlangen
Outcome results
None listed